Ocugen Hits A Stumbling Block for Its COVID-19 Vaccine Candidate

The FDA has placed a clinical hold on Ocugen’s Investigational New Drug (IND) application for BBV152, the company’s COVID-19 vaccine candidate known as Covaxin outside the U.S.
Source: Drug Industry Daily